Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.
Rubió-Casadevall J, Cirauqui Cirauqui B, Martinez Trufero J, Plana Serrahima M, García Castaño A, Carral Maseda A, Iglesias Docampo L, Pérez Segura P, Ceballos Lenza I, Gutiérrez Calderón V, Fuster Salvà J, Pena Álvarez C, Hernandez I, Del Barco Morillo E, Chaves Conde M, Martínez Galán J, Durán Sánchez M, Quiroga V, Ortega E, Mesia R. Rubió-Casadevall J, et al. Among authors: del barco morillo e. Front Oncol. 2023 Aug 1;13:1226939. doi: 10.3389/fonc.2023.1226939. eCollection 2023. Front Oncol. 2023. PMID: 37601652 Free PMC article.
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer.
Chinchilla-Tábora LM, Montero JC, Corchete LA, González-Morais I, Del Barco Morillo E, Olivares-Hernández A, Rodríguez González M, Sayagués JM, Ludeña MD. Chinchilla-Tábora LM, et al. Among authors: del barco morillo e. Int J Mol Sci. 2024 Feb 8;25(4):2048. doi: 10.3390/ijms25042048. Int J Mol Sci. 2024. PMID: 38396726 Free PMC article.
Complications Secondary to the Use Of Sglt2 Inhibitors in Oncological Patients: A Series of 5 Cases.
Posado-Domínguez L, Figuero-Pérez L, Aránzazu Amores-Martín M, Reguera-Puertas P, Martín-Galache M, Del Barco-Morillo E, Fonseca-Sánchez E. Posado-Domínguez L, et al. Among authors: del barco morillo e. Eur J Case Rep Intern Med. 2023 Dec 6;11(1):004216. doi: 10.12890/2023_004216. eCollection 2024. Eur J Case Rep Intern Med. 2023. PMID: 38223287 Free PMC article.
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
Ospina AV, Bolufer Nadal S, Campo-Cañaveral de la Cruz JL, González Larriba JL, Macía Vidueira I, Massutí Sureda B, Nadal E, Trancho FH, Álvarez Kindelán A, Del Barco Morillo E, Bernabé Caro R, Bosch Barrera J, Calvo de Juan V, Casal Rubio J, de Castro J, Cilleruelo Ramos Á, Cobo Dols M, Dómine Gómez M, Figueroa Almánzar S, Garcia Campelo R, Insa Mollá A, Jarabo Sarceda JR, Jiménez Maestre U, López Castro R, Majem M, Martinez-Marti A, Martínez Téllez E, Sánchez Lorente D, Provencio M. Ospina AV, et al. Among authors: del barco morillo e. Clin Transl Oncol. 2024 Mar 26. doi: 10.1007/s12094-024-03382-y. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38530556 Review.
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
Hitt R, Mesía R, Lozano A, Iglesias Docampo L, Grau JJ, Taberna M, Rubió-Casadevall J, Martínez-Trufero J, Morillo EDB, García Girón C, Vázquez Estévez S, Cirauqui B, Cruz-Hernández JJ. Hitt R, et al. Among authors: morillo edb. Oral Oncol. 2022 Nov;134:106087. doi: 10.1016/j.oraloncology.2022.106087. Epub 2022 Sep 18. Oral Oncol. 2022. PMID: 36126605 Clinical Trial.
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy.
Olivares-Hernández A, Del Barco Morillo E, Miramontes-González JP, Figuero-Pérez L, Pérez-Belmonte L, Martín-Vallejo J, Martín-Gómez T, Escala-Cornejo R, Vidal-Tocino R, Hernández LB, Sarmiento RG, Ludeña de la Cruz MD, Cruz-Hernández JJ, Pérez CP. Olivares-Hernández A, et al. Among authors: del barco morillo e. Front Biosci (Landmark Ed). 2022 Mar 8;27(3):88. doi: 10.31083/j.fbl2703088. Front Biosci (Landmark Ed). 2022. PMID: 35345320 Free article.
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.
Ruano-Ravina A, Provencio M, Calvo de Juan V, Carcereny E, Estival A, Rodríguez-Abreu D, Benítez G, López-Castro R, Belver M, Guirado-Risueño M, Guirao-Rubio C, Blasco A, Massutí B, Ortega AL, Cobo M, Mosquera-Martínez J, Aguado de la Rosa C, Bosch-Barrera J, Sánchez-Gastaldo A, Del Barco Morillo E, Juan Ó, Dómine M, Trigo JM, Pereiro Corbacho D, Oramas J. Ruano-Ravina A, et al. Among authors: del barco morillo e. Transl Lung Cancer Res. 2021 Oct;10(10):3902-3911. doi: 10.21037/tlcr-21-559. Transl Lung Cancer Res. 2021. PMID: 34858780 Free PMC article.
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data.
Toribio-García I, Olivares-Hernández A, Miramontes-González JP, Domínguez LP, Martín García A, Eiros Bachiller R, Figuero-Pérez L, Garijo Martínez M, Roldán Ruiz J, Bellido Hernández L, Fonseca-Sánchez E, Luis Sánchez P, Del Barco-Morillo E. Toribio-García I, et al. Among authors: del barco morillo e. Cancers (Basel). 2023 Aug 28;15(17):4293. doi: 10.3390/cancers15174293. Cancers (Basel). 2023. PMID: 37686569 Free PMC article.
16 results